KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Non-Current Debt (2016 - 2022)

Pacific Biosciences Of California has reported Non-Current Debt over the past 12 years, most recently at $500000.0 for Q4 2022.

  • Quarterly results put Non-Current Debt at $500000.0 for Q4 2022, down 78.26% from a year ago — trailing twelve months through Dec 2022 was $500000.0 (down 78.26% YoY), and the annual figure for FY2022 was $500000.0, down 78.26%.
  • Non-Current Debt for Q4 2022 was $500000.0 at Pacific Biosciences Of California, down from $2.3 million in the prior quarter.
  • Over the last five years, Non-Current Debt for PACB hit a ceiling of $15.8 million in Q4 2019 and a floor of $500000.0 in Q4 2022.
  • Median Non-Current Debt over the past 4 years was $14.1 million (2018), compared with a mean of $10.8 million.
  • Biggest five-year swings in Non-Current Debt: soared 37.57% in 2018 and later plummeted 78.26% in 2022.
  • Pacific Biosciences Of California's Non-Current Debt stood at $14.7 million in 2018, then increased by 7.78% to $15.8 million in 2019, then tumbled by 85.44% to $2.3 million in 2021, then plummeted by 78.26% to $500000.0 in 2022.
  • The last three reported values for Non-Current Debt were $500000.0 (Q4 2022), $2.3 million (Q4 2021), and $15.8 million (Q4 2019) per Business Quant data.